Nov 1 (Reuters)-
Wakamoto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2018 Sep 30, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5.23 5.42 11.10
(-3.6 pct) (-1.2 pct) (+1.8 pct)
Operating loss 44 mln loss 105 mln loss 510 mln
Recurring loss 29 mln loss 108 mln loss 510 mln
Net loss 31 mln loss 84 mln loss 380 mln
EPS loss 0.91 yen loss 2.43 yen loss 10.95 yen
Ann Div 3.00 yen
-Q2 div NIL NIL
-Q4 div 3.00 yen
NOTE - Wakamoto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T